Brief: Radiopharm Theranostics Confirmed Guidance Of Cash Runway Through To Mid-2026
29/07/2025 12:34
July 29 (Reuters) - Radiopharm Theranostics Ltd RAD.AX: RADIOPHARM THERANOSTICS REPORTS FISCAL YEAR 2025 FINANCIAL RESULTS AND BUSINESS UPDATE RADIOPHARM THERANOSTICS LTD: CONFIRMED GUIDANCE OF CASH RUNWAY THROUGH TO MID-2026 RADIOPHARM THERANOSTICS LTD - FDA GRANTS FAST TRACK DESIGNATION FOR RAD101 Source text: ID:nGNX1RP6GZ Further company coverage: RAD.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Radiopharm Theranostics
See all newsNASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
Brief: Radiopharm Theranostics To Meet With U.S. FDA To Align On Pivotal Phase 3 Trial Design For Rad 101 In Diagnosis Of Brain Metastases
NASDAQ RESUMED AT 09:56 AM
NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 09:50 AM